Skip to content

Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study

Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06076616
Acronym
BREHAB
Enrollment
40
Registered
2023-10-11
Start date
2022-12-01
Completion date
2024-01-01
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Lifestyle, Prehabilitation, Rehabilitation, Surgery

Brief summary

Prehabilitation and rehabilitation through personalized lifestyle counseling in patients with breast cancer.

Interventions

BEHAVIORALPrehabilitation and rehabilitation

A personalized lifestyle counseling programme.

Sponsors

Franciscus Gasthuis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A pilot study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Woman with a confirmed breast cancer diagnosis 2. Planned surgical treatment of breast cancer 3. Age 18 years or older 4. Provision of written informed consent

Exclusion criteria

1. Severe mental retardation, which limits the ability to follow instructions independently 2. Severe psychiatric problems, which limits the ability to follow instructions independently 3. Legal incapacity 4. Language barrier: If we cannot find a lifestyle coach who speaks the patient's language, unfortunately we cannot offer the lifestyle coaching in its entirety, and this option will be omitted for the patient.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment/consent rateFrom baseline to 6 months postoperativelyTo estimate patient recruitment/consent rate to the prehabilitation/rehabilitation group Enrolment logs will be recorded for all patients who meet the eligibility criteria. Reasons for non-participation will be recorded. We define a success criterion of 40% of the total number of participants invited to be recruited to the pilot study.
Attendance rateFrom baseline to 6 months postoperativelyTo estimate patient attendance, measured by the number of sessions attended out of 10. Reasons for non-attendance will be collected and withdrawals tracked. We will consider an attendance rate of 80% satisfactory
Patient adherenceFrom baseline to 6 months postoperativelyTo estimate patient adherence monitored with the aid of the wearables. Adherence is defined as at least 150 min of moderate intensity exercise and at least two strength training sessions per week. Exercise instructions are based on the Health Council's exercise guidelines. We will consider an adherence of 70% as satisfactory.
WithdrawalsFrom baseline to 6 months postoperativelyTo estimate the number of withdrawals, defined as the proportion of patients who quit the intervention before reaching the primary endpoint (HRQOL at six months after surgery). Information about the reasons for withdrawal will be collected.
Patient satisfactionFrom baseline to 6 months postoperativelyTo estimate patient satisfaction with the programme assessed during three interviews: at four weeks, at three months after surgery and at the end of the study. Satisfaction is defined as: satisfaction with the lifestyle coach, satisfaction with the duration of the intervention, satisfaction with the physical training programme. Patients will be given room for their own input to improve the intervention.
Selection biasFrom baseline to 6 months postoperativelyTo explore any evidence of selection bias in participants recruited into the study (assessed through participant characteristics at baseline).

Secondary

MeasureTime frameDescription
Likely changes in mean score of the different BREAST-Q scalesThe questionnaire will be administered at enrolment and at six months after surgery.Measured using the BREAST-Q questionnaire
Likely changes in mean score of quality of life by means of the EORTC-BR23 questionnaireThe questionnaire will be administered at enrolment and at six months after surgery.Measured using the EORTC-BR23 questionnaire
Likely changes in Health Related Quality of Life (HRQOL)Baseline, the day before surgery, 6 months postoperativelyTo investigate likely changes in the primary outcome measure HRQOL measured with the EORTC-QLQ-30 questionnaire at six months after surgery.
Likely changes in mean score of the EQ5D-5L questionnaireThe questionnaire will be administered at enrolment and at six months after surgery.Measured using the EQ-5D-5L questionnaire
Likely changes in mean score of the different EORTC-QLQ-30 scales which will be administered at enrolment and six months after surgery.The questionnaire will be administered at enrolment and at six months after surgery.Measured using the EORTC-QLQ-30 questionnaire
Likely changes in BMIBaseline, the day before surgery, 6 months postoperativelyBody Mass Index
Likely changes in functional capacity (physical fitness)Baseline, the day before surgery, 6 months postoperativelyMeasured using the 6 minute walking test (6MWT)
Likely changes in the number of postoperative complications30 days after surgeryComplications within 30 days after surgery, measured with the Comprehensive Complication Index (CCI)
Likely changes in smoking statusMeasured at baseline and 6 months postoperativelySmoking status (yes/no) as assessed by the primary investigator
Likely changes in postoperative functional recoveryThe day after surgeryMeasured the day after surgery with the MILAS and DEMMI questionnaires

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026